YIDU TECH Affiliate Wins Bid for Hainan Provincial Infectious Disease Surveillance Platform Phase II

Stock News04-13 12:28

YIDU TECH (02158) announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has recently been awarded the contract for the Provincial Coordinated Regional Infectious Disease Surveillance, Early Warning, and Emergency Command Information Platform (Hainan Phase II) project. The total contract value is approximately RMB 12.89 million. YIDU TECH is a core driver of intelligent upgrades within China's healthcare system. The company empowers the entire industry chain—encompassing healthcare, pharmaceuticals, insurance, and patients—through advanced intelligent decision-making, aiming to make precision medicine accessible to everyone. By simulating the clinical decision-making logic of physicians, using real disease progression as training data, and repeatedly validating findings in real-world settings, the company has developed an AI that truly understands diseases. This provides measurable value to key parts of the medical ecosystem: equipping doctors with more precise and efficient decision-making tools, helping pharmaceutical companies shorten the path from molecule to patient, enabling patients to access more affordable precision diagnosis and treatment, and providing public health systems with more scientific support. Through its proprietary system-level intelligence, YIDU TECH is creating a more resilient, caring, efficient, and universally accessible future for healthcare.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment